Li-An Yeh, PhD
Director of BRITE & Professor of Pharmaceutical Sciences (Retired)
Biomanufacture Research Institute Technology Enterprise (BRITE)
NC Central University
Dr. Yeh received her Ph.D. degree at Purdue University in biochemistry 1980, and then she gained 3 year post-doctoral experience at Harvard University. She started her drug discovery research career at Pfizer Central Research, R&D in 1984. During 1992 to 2001, she joined three biotechnology companies working as a scientific director, including OsteoArthritis Science, Phytera Inc and NEN-Life Science. In 2001, she joined Laboratory for Drug Discovery in Neurodegeneration (LDDN) as the Director, Lead Discovery at Brigham Women Hospital/Harvard Medical School. In 2004, she was recruited by Eli Lilly as a Research Advisor in Lead Generation Biology. In June, 2005 she became the Director, BRITE (Biomanufacture Research Institute Technology Enterprise) and Professor of Pharmaceutical Sciences at North Carolina Central University.
Her research experience in drug discovery included neurodegeneration, diabetes, anti-ulcer, osteoporosis, osteoarthritis, infectious diseases (anti-viral, anti-fungal and anti-microbial), and cancer. Her current research interest focuses on drug discovery in diseases related to neurodegeneration. She established a new academic program at BRITE/NCCU in 2007. The mission of this program is to educate students to have scientific competence to work in pharmaceutical and biomanufacturing industry at B.S., M.S. and Ph.D. levels. Currently, the new degree program has total of 49 faculty and staff to support 160 students. The BRITE center also has established research program in drug discovery and drug biomanufacturing areas.
Dr. Yeh has published 50 papers in the peer review journals and holds several patents.